PC
ISEE

Polar Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Polar Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7,250
Closed -$334K – 272
2016
Q3 		$334K Sell
7,250
-35,826
-83% -$2.02M 0.01% 251
2016
Q2 		$2.2M Buy
43,076
+23,756
+123% +$1.18M 0.04% 219
2016
Q1 		$817K Buy
+19,320
New +$984K 0.02% 241
2015
Q4 		– Sell
-14,316
Closed -$580K – 293
2015
Q3 		$580K Buy
+14,316
New +$758K 0.01% 257

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Polar Capital's ISEE Position: Q4 2016 in Review

Polar Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 7,250 shares — an estimated $334K sold.

Polar Capital first reported a position in ISEE in Q3 2015 and held it in 4 quarters. The position peaked at $2.2M in Q2 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Polar Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Polar Capital sold 7,250 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $334K.
  • Polar Capital first reported a position in IVERIC bio, Inc. Common Stock in Q3 2015 and held it in 4 quarters.
  • Polar Capital's IVERIC bio, Inc. Common Stock position peaked at $2.2M in Q2 2016.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Polar Capital's 13F filing for Q4 2016, filed 14 Feb 2017.